Ticker Details
Pyxis Oncology, Inc.
IPO Date:	October 8, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$88.42M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 4.14%
Avg Daily Range (30 D):	$0.08 | 5.11%
Avg Daily Range (90 D):	$0.14 | 5.14%

Institutional Daily Volume
Avg Daily Volume:	.62M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	1.02M

Trade Size
Avg Trade Size (Sh.):	178
Avg Trade Size (Sh.) (30 D):	232
Avg Trade Size (Sh.) (90 D):	186

Institutional Trades
Total Institutional Trades:	57
Avg Institutional Trade:	$1.96M
Avg Institutional Trade (30 D):	$.51M
Avg Institutional Trade (90 D):	$.73M
Avg Institutional Trade Volume:	.57M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.68M
Avg Closing Trade (30 D):	$4.38M
Avg Closing Trade (90 D):	$4.38M
Avg Closing Volume:	1.47M

News

Jun 28, 2024 @ 8:30 PM Pyxis Oncology Reports Inducement Grants Under Nas... Source: Pyxis Oncology

Jun 10, 2024 @ 11:30 AM Pyxis Oncology Expands Board of Directors with App... Source: Pyxis Oncology

May 30, 2024 @ 11:30 AM Pyxis Oncology to Participate in a Fireside Chat a... Source: Pyxis Oncology

May 14, 2024 @ 12:40 PM Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops ... Source: Zacks Equity Research

Apr 12, 2024 @ 1:55 PM Does Pyxis Oncology (PYXS) Have the Potential to R... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.59	$-.35	$-.3
Diluted EPS	$-1.59	$-.35	$-.3
Revenue	$2.82M	$M	$2.82M
Gross Profit
Net Income / Loss	$-97.09M	$-22M	$-18.35M
Operating Income / Loss	$-106.19M	$-23.46M	$-19.75M
Cost of Revenue
Net Cash Flow	$-3.14M	$-1.81M	$-8.74M
PE Ratio